Top compounds associated with response to ARF1


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC -0.071 0.1
mRNA tivozanib CTRPv2 pan-cancer AAC -0.049 0.2
mRNA tivozanib GDSC1000 pan-cancer AAC -0.026 0.4
mRNA tosedostat CTRPv2 pan-cancer AAC 0.04 0.3
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.02 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.0016 1
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.067 0.08
mRNA triptolide CTRPv2 pan-cancer AAC 0.054 0.1
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.15 0.003
Download CSV